Literature DB >> 9603908

Cot kinase activates tumor necrosis factor-alpha gene expression in a cyclosporin A-resistant manner.

A Ballester1, A Velasco, R Tobeña, S Alemany.   

Abstract

Cot kinase is a protein serine/threonine kinase, classified as a mitogen-activated protein kinase kinase kinase, implicated in T lymphocyte activation. Here we show that an increase in Cot kinase expression promotes tumor necrosis factor-alpha (TNF-alpha) production in Jurkat T cells stimulated by soluble anti-CD3 or by low concentrations of phorbol 12,13-dibutyrate (PDBu) and calcium ionophore. Overexpression of Cot kinase in Jurkat cells activates TNF-alpha gene expression. Cot kinase promotes TNF-alpha promoter activation to a similar extent as calcium ionophore and PDBu or soluble anti-CD28 and PDBu. Neither phorbol esters nor calcium ionophore can replace Cot kinase on TNF-alpha promoter-driven transcription. Expression of a dominant negative form of Cot kinase inhibits TNF-alpha promoter activation induced by stimulation with either calcium ionophore and PDBu, soluble anti-CD28 and PDBu, or soluble anti-CD3 and PDBu. TNF-alpha promoter-driven transcription by Cot kinase is partially mediated by MAPK/ERK kinase and is cyclosporin A-resistant. Cot kinase increases at least the AP-1 and AP-2 response elements. These data indicate that Cot kinase plays a critical role in TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603908     DOI: 10.1074/jbc.273.23.14099

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.

Authors:  Maria Luisa Gándara; Pilar López; Raquel Hernando; José G Castaño; Susana Alemany
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  Cot kinase plays a critical role in Helicobacter pylori-induced IL-8 expression.

Authors:  Sungil Jang; Jinmoon Kim; Jeong-Heon Cha
Journal:  J Microbiol       Date:  2017-03-31       Impact factor: 3.422

3.  Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.

Authors:  Yukiko Kuroda; Chihiro Hisatsune; Akihiro Mizutani; Naoko Ogawa; Koichi Matsuo; Katsuhiko Mikoshiba
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

4.  Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation.

Authors:  M Chiariello; M J Marinissen; J S Gutkind
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription.

Authors:  Lawrence P Kane; Marianne N Mollenauer; Zheng Xu; Christoph W Turck; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

6.  Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity.

Authors:  Hong Seok Choi; Bong Seok Kang; Jung-Hyun Shim; Yong-Yeon Cho; Bu Young Choi; Ann M Bode; Zigang Dong
Journal:  FASEB J       Date:  2007-08-27       Impact factor: 5.191

7.  Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages.

Authors:  Marta López-Pelaéz; Stefano Fumagalli; Carlos Sanz; Clara Herrero; Susana Guerra; Margarita Fernandez; Susana Alemany
Journal:  Mol Biol Cell       Date:  2012-06-06       Impact factor: 4.138

Review 8.  Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.

Authors:  Hye Won Lee; Han Yong Choi; Kyeung Min Joo; Do-Hyun Nam
Journal:  Int J Mol Sci       Date:  2015-02-25       Impact factor: 5.923

9.  Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8.

Authors:  Kaushal Parikh; Sander H Diks; Jurriaan H B Tuynman; Auke Verhaar; Mark Löwenberg; Daan W Hommes; Jos Joore; Akhilesh Pandey; Maikel P Peppelenbosch
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

10.  Expression of the Tpl2/Cot oncogene in human T-cell neoplasias.

Authors:  Anna V Christoforidou; Helen A Papadaki; Andrew N Margioris; George D Eliopoulos; Christos Tsatsanis
Journal:  Mol Cancer       Date:  2004-12-03       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.